R53G (p.Arg53Gly) variant of PAH (Phenylalanine-4-hydroxylase)

R53G (p.Arg53Gly) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in PAH deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.62 / 1. The record also includes structural context.

R53G (p.Arg53Gly) variant details